Stedman's medical dictionary defines lethargy as a "relatively mild impairment of consciousness resulting in reduced alertness and awareness; this condition has many causes but is ultimately due to generalized brain dysfunction."
A new study points out the risk of nonsteroidal anti-inflammatory drug (NSAID) use in patients who have had a myocardial infarction (MI) suggesting that even brief use increases the risk for death and recurrent MI.
The FDA has approved linagliptin for the treatment of type 2 diabetes in adults.
The FDA has approved two new drugs for the treatment of hepatitis C the first new drugs to be approved in years.
Niacin may not be effective in preventing cardiovascular disease.
